Digital Therapeutics Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Digital Therapeutics Market to 2025 - Global Analysis and Forecasts By Application (Respiratory Diseases, Central Nervous System Disease, Smoking Cessation, Medication Adherence, Cardiovascular Diseases, Musculoskeletal Diseases, and Other Applications), Distribution Channels (B2B and B2C), and Geography

Report Code: TIPHC00002236 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and lifestyle changes usually spurred by a collection of digital impetuses. Because of the digital nature of the methodology, data can be collected and analyzed as both a progress report and a preventative measure.

The market of digital therapeutics market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence and incidence of chronic diseases in the global population, growing attention on preventive healthcare. Various technological developments in the healthcare industry, major increase in endeavor capital investments in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the market.

The "Global Digital Therapeutics Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global digital therapeutics market with detailed market segmentation by application, distribution channel, and geography. The global digital therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the digital therapeutics market.

The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global digital therapeutics market based on application, distribution channel, and geography. It also provides market size and forecast till 2025 for overall digital therapeutics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The digital therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is estimated to contribute to the largest share in the digital therapeutics market in the coming years, owing to factors such as, improved healthcare infrastructure and rising number of chronic disorders, initiatives of government to support technological improvements in digital therapeutics, gradually improving refund structure for digital therapeutics solutions in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the growth of healthcare industry in Asian countries such as, India, China and Japan.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key digital therapeutics market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Propeller Health, CANARY HEALTH, Noom, Inc., 2Morrow Inc., Livongo Health, Proteus Digital Health, WellDoc, Inc, Twine Health, Inc., Omada Health, Inc., and Mango Health among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. DIGITAL THERAPEUTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Digital Therapeutics Market - By Application
3.2.2. Digital Therapeutics Market - By Distribution Channel
3.2.3. Digital Therapeutics Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East & Africa - PEST Analysis
3.3.5. South & Central America- PEST Analysis

4. DIGITAL THERAPEUTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS

5. DIGITAL THERAPEUTICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL DIGITAL THERAPEUTICS MARKET OVERVIEW
5.2. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 - BY APPLICATION
6.1. OVERVIEW
6.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. RESPIRATORY DISEASES MARKET
6.3.1. Overview
6.3.2. Respiratory Diseases Market Revenue Forecasts and Analysis (US$ Mn)
6.4. CENTRAL NERVOUS SYSTEM DISEASE MARKET
6.4.1. Overview
6.4.2. Central Nervous System Disease Market Revenue Forecasts and Analysis (US$ Mn)
6.5. SMOKING CESSATION MARKET
6.5.1. Overview
6.5.2. Smoking Cessation Market Revenue Forecasts and Analysis (US$ Mn)
6.6. MEDICATION ADHERENCE MARKET
6.6.1. Overview
6.6.2. Medication Adherence Market Revenue Forecasts and Analysis (US$ Mn)
6.7. CARDIOVASCULAR DISEASES MARKET
6.7.1. Overview
6.7.2. Cardiovascular Diseases Market Revenue Forecasts and Analysis (US$ Mn)
6.8. MUSCULOSKELETAL DISEASES MARKET
6.8.1. Overview
6.8.2. Musculoskeletal Diseases Market Revenue Forecasts and Analysis (US$ Mn)
6.9. OTHER APPLICATIONS MARKET
6.9.1. Overview
6.9.2. Other Applications Market Revenue Forecasts and Analysis (US$ Mn)
7. DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 - BY DISTRIBUTION CHANNEL
7.1. OVERVIEW
7.2. DISTRIBUTION CHANNEL MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. B2B MARKET
7.3.1. Overview
7.3.2. B2B Market Revenue Forecasts and Analysis (US$ Mn)
7.3.3. Caregivers Market
7.3.3.1. Overview
7.3.3.2. Caregivers Market Revenue Forecasts and Analysis (US$ Mn)
7.3.4. Patient Market
7.3.4.1. Overview
7.3.4.2. Patient Market Revenue Forecasts and Analysis (US$ Mn)
7.4. B2C MARKET
7.4.1. Overview
7.4.2. B2C Market Revenue Forecasts and Analysis (US$ Mn)
7.4.3. Providers Market
7.4.3.1. Overview
7.4.3.2. Providers Market Revenue Forecasts and Analysis (US$ Mn)
7.4.4. Payers Market
7.4.4.1. Overview
7.4.4.2. Payers Market Revenue Forecasts and Analysis (US$ Mn)
7.4.5. Other Buyer Market
7.4.5.1. Overview
7.4.5.2. Other Buyer Market Revenue Forecasts and Analysis (US$ Mn)

?
8. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
8.1. NORTH AMERICA DIGITAL THERAPEUTICS MARKET OVERVIEW
8.2. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
8.4. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISTRIBUTION CHANNEL (US$ MN)
8.5. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.6.2. US Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7.2. Canada Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8.2. Mexico Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. EUROPE DIGITAL THERAPEUTICS MARKET OVERVIEW
9.2. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
9.4. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISTRIBUTION CHANNEL (US$ MN)
9.5. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
?
9.6. UK MARKET OVERVIEW
9.6.1. UK Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.6.2. UK Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7.2. Germany Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
9.8. FRANCE MARKET OVERVIEW
9.8.1. France Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8.2. France Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution Channel (US$ Mn)
10. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET OVERVIEW
10.2. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
10.4. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISTRIBUTION CHANNEL (US$ MN)
10.5. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. JAPAN MARKET OVERVIEW
10.6.1. Japan Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.6.2. Japan Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution channel (US$ Mn)
10.7. CHINA MARKET OVERVIEW
10.7.1. China Digital Therapeutics Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7.2. China Digital Therapeutics Market Revenue Forecasts and Analysis - By Distribution channel (US$ Mn)
10.8. INDIA MARKET OVERVIEW
10.8.1. India Digital therapeutics market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8.2. India Digital therapeutics market Revenue Forecasts and Analysis - By Distribution channel (US$ Mn)
11. MIDDLE EAST AND AFRICA (MEA) DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
11.4. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISTRIBUTION CHANNEL (US$ MN)
11.5. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Digital therapeutics market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.6.2. South Africa Digital therapeutics market Revenue Forecasts and Analysis - By Distribution channel (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Digital therapeutics market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7.2. Saudi Arabia Digital therapeutics market Revenue Forecasts and Analysis - By Distribution channel (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Digital therapeutics market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8.2. UAE Digital therapeutics market Revenue Forecasts and Analysis - By Distribution channel (US$ Mn)
12. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY APPLICATION (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISTRIBUTION CHANNEL (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Digital therapeutics market Revenue Forecasts and Analysis - By Application (US$ Mn)
12.6.2. Brazil Digital therapeutics market Revenue Forecasts and Analysis - By Distribution channel (US$ Mn)
13. DIGITAL THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. PROPELLER HEALTH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product/Service Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CANARY HEALTH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product/Service Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. NOOM, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product/Service Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. 2MORROW INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product/Service Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. LIVONGO HEALTH
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product/Service Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PROTEUS DIGITAL HEALTH
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product/Service Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. WELLDOC, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product/Service Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TWINE HEALTH, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product/Service Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. OMADA HEALTH, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product/Service Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MANGO HEALTH
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product/Service Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
The List of Companies

1 PROPELLER HEALTH
2 CANARY HEALTH
3 Noom, Inc.
4 2Morrow Inc.
5 Livongo Health
6 PROTEUS DIGITAL HEALTH
7 WellDoc, Inc
8 Twine Health, Inc.
9 Omada Health, Inc.
10 MANGO HEALTH

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book